Cataract
Share your love
Fluorescent Gel Boosts Cataract Surgery Safety
Cataracts, a condition that clouds the eye’s lens and impairs vision, are a near-universal experience with age. To improve safety in cataract surgery, scientists at Johns Hopkins have engineered a novel color-changing hydrogel that can help surgeons avoid complications in…
EPOMEC 2024: Ophthalmology Conference Highlights
The Evolving Practice of Ophthalmology Middle East Conference (EPOMEC) is set to take place from December 5–7, 2024, at the Dubai World Trade Centre, United Arab Emirates. This prestigious event brings together the latest advancements in ophthalmology from across the…
The Royal College of Ophthalmologists’ National Ophthalmology Database study of cataract surgery: report 19, a comparative study of the cost and carbon footprint of local anaesthesia techniques for cataract surgery | Eye – Nature
The Royal College of Ophthalmologists’ National Ophthalmology Database study of cataract surgery: report 19, a comparative study of the cost and carbon footprint of local anaesthesia techniques for cataract surgery | Eye Nature Source: Author: | Date: 2024-11-23 08:00:00 Source: Author:…
Positive Phase 3 Results for MELT-300 Sedation
Melt Pharmaceuticals has reported promising topline results from the pivotal Phase 3 trial of MELT-300, a novel, non-intravenous, non-opioid sedation tablet developed for use during cataract surgeries. The study, conducted under an FDA-approved Special Protocol Assessment (SPA) agreement, demonstrated that…
SERI and ZEISS Partner to Improve Vision Care
The Singapore Eye Research Institute (SERI) and Carl Zeiss Meditec have launched a groundbreaking collaboration aimed at advancing cataract and refractive surgery outcomes. The initiative, called Ophthalmic Tech Innovation by ZEISS and SERI (OPTIZS), involves a combined investment of nearly…
Alcon’s IOL Faces Probe by CDSCO
The Central Drugs Standard Control Organisation (CDSCO) has formed a committee to investigate allegations of quality issues with an intraocular lens (IOL) supplied by Alcon. The Swiss-American company specializes in eye care products, including lenses for cataract surgery. Specifics of…
OBN Spotlight TV: Interview with Hillary A. Golden
In late October, Medicare introduced proposed Local Coverage Determinations (LCDs) that aimed to impose restrictions on Minimally Invasive Glaucoma Surgery (MIGS) procedures. These LCDs were met with significant concern and opposition from medical professionals, patient advocacy groups, and the ophthalmology…
Top 15 International Ophthalmology Congresses in 2024
As the field of ophthalmology continues to advance, a plethora of international congresses offer opportunities for professionals to explore the latest innovations, share insights, and foster collaborations. Here is a comprehensive list of the top 15 international ophthalmology conferences scheduled…
Tarsus Appoints Dr. Elizabeth Yeu as Chief Medical Officer
Tarsus Pharmaceuticals has announced the appointment of Elizabeth Yeu, MD, as Chief Medical Officer, effective November 4, 2024. Dr. Yeu, an esteemed ophthalmologist with over two decades of clinical and leadership experience, will lead the company’s medical organization and oversee…
Formosa: Positive Phase 3 Results for APP13007 in China
Formosa Pharmaceuticals recently announced the completion of CPN-303, a Phase 3 clinical trial conducted in Chinese cataract surgery patients to evaluate APP13007 (GPN00833). This trial, managed by Formosa’s licensee Grand Pharma (0512.HK), demonstrated positive top-line results, showcasing APP13007’s effectiveness in…